Farma

Svensson1
12.11.2018 kl 21:03 1543

Info from Kaydence to interested investors (people who have submitted their mail address via the link in the bottom of this post).:
---------------------------------
The preliminary private placement efforts have gone extremely well – in fact, they have exceeded expectations.
Based on remaining placement positions and progress toward the overall target, Kaydence is considering a reduced minimum subscription level of 15.000 Euro.
The number of participants is limited due to applicable regulations on private placement transactions.
---------------------------------
Please contact the company or follow the links in case you are interested in the placement.

https://www.joinkaydence.com/
https://www.realtid.se/kaydence-pharma-ser-miljardmarknad-sitt-syntetiska-vitamin-k2
Redigert 12.11.2018 kl 21:03

Rapportér innlegg

Vennligst skriv inn kommentar på hva du mener er upassende og trykk send. Dersom kommentar ikke er nødvendig, vennligst trykk send direkte.
E-postadressen brukes kun for å få kontakt med deg i forbindelse med advarselen.
E-postadressen brukes kun for å få kontakt med deg i forbindelse med advarselen.